DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

0.41 0.01 (2.50%)

Quote as of


company name or ticker

Recent Quotes

IMUC $0.41 2.50%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.41
Previous Close $0.40
Daily Range $0.40 - $0.43
52-Week Range $0.35 - $1.04
Market Cap $37.0M
P/E Ratio -3.33
Dividend (Yield) $0.00 (0.0%)
Volume 188,120
Average Daily Volume 609,605
Current FY EPS -$0.13

Sector

Healthcare

Industry

Healthcare IT

ImmunoCellular Therapeutics, Ltd. (IMUC) Description

ImmunoCellular Therapeutics, Ltd. Website: http://www.imuc.com/

News & Commentary Rss Feed

3 Possible Catalysts for Inovio Pharmaceuticals in 2014

Inovio Pharmaceuticals could be a stock to watch in 2014 for these three reasons.

ImmunoCellular Announces Update on ICT-107

ImmunoCellular Therapeutics Letter to Shareholders Highlights Progress on Advancing ICT-107 to Phase

ImmunoCellular Therapeutics Letter to Shareholders Highlights Progress on Advancing ICT-107 to Phase 3 Registrational Trial

Health Care Sector Update for 08/13/2015: OCUL, IMUC

ImmunoCellular's (IMUC) CEO Andrew Gengos on Q1 2015 Results - Earnings Call Transcript

Next Week In Biotech: Salix/Valeant PDUFA, ASCO, Brain Tumor Summit

ImmunoCellular's (IMUC) CEO Andrew Gengos on Q1 2015 Results - Earnings Call Transcript

4 Points For Northwest Bio Longs To Ponder

Northwest Bio: FDA Panel Recommendation On Amgen's Cancer Vaccine Is Significant For DCVax-L And DCV

Northwest Bio: FDA Panel Recommendation On Amgen's Cancer Vaccine Is Significant For DCVax-L And DCVax Direct

ImmunoCellular's (IMUC) CEO Andrew Gengos on Q4 2014 Results - Earnings Call Transcript

NeoStem: The Levi Strauss Of Cell Therapy

See More IMUC News...

IMUC's Top Competitors

IMUC $0.41 (2.50%)
Current stock: IMUC
PFE $32.66 (-1.80%)
Current stock: PFE
JNJ $95.17 (-1.09%)
Current stock: JNJ
RHHBY $34.16 (-1.98%)
Current stock: RHHBY